| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.01 | 1 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.00094 | 1 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.00062 | 1 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.00047 | 1 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.00062 | 1 |